Today Aug 05, 2021
Event Image
Back to Events

An Overview of CLL and the Use of a Targeted Agent for Previously Untreated or R/R CLL

Wednesday Jul 21, 2021
Event Time 12:15 - 12:45 PM ET
Registration Closed
Event Faculty

Quoc Truong, MD

Hematology/Oncology Physician
Cancer Center of Kansas
Wichita, KS

This program presents clinical efficacy and safety data supporting the use of a selective Bruton Tyrosine Kinase inhibitor for the treatment of previously untreated and R/R CLL.

Event Sponsors